[National Institutes of Health](https://www.nih.gov/)

July 1, 2026 (estimated)

Estimated total program funding: $4,500,000; ~8 awards expected

Supports discovery and mechanistic research to advance understanding of cardiovascular disease in type 1 diabetes via the CARE-T1D consortium.

Forecasted opportunity; details and dates may change—monitor program page for updates.

--- ## Description The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the National Heart, Lung, and Blood Institute, plans to continue supporting the CARE-T1D consortium for research into cardiovascular disease in type 1 diabetes (T1D). This funding opportunity will solicit applications for discovery and mechanistic studies—particularly those using multi-omics and molecular approaches—to better understand the pathogenesis of cardiac disease in T1D. Collaborative projects that combine expertise in type 2 diabetes, atherosclerosis, inflammation, and advanced omics techniques are encouraged. The program will use the U01 cooperative agreement mechanism and is open to investigators with relevant expertise in T1D cardiovascular disease. --- ## Due Dates - Estimated application due date: July 1, 2026 *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Estimated total program funding: $4,500,000 - Approximately 8 awards expected - Award ceiling and floor not specified --- ## Eligibility Eligible applicants include: - State, county, and local governments - Independent school districts - Public and private institutions of higher education - Nonprofits with 501(c)(3) status - For-profit organizations (including small businesses) - Native American tribal governments and organizations (both federally recognized and other) - Public housing authorities/Indian housing authorities - U.S. territories and possessions - Faith-based and community-based organizations - Regional organizations - Eligible agencies of the federal government - Non-domestic (non-U.S.) entities (foreign institutions) --- ## Application Process - This is a forecasted opportunity; the official Notice of Funding Opportunity (NOFO) will be published in the future. - Applications will be submitted via [Grants.gov](https://www.grants.gov/search-results-detail/360626). - Prepare to address discovery and mechanistic research objectives as outlined by the CARE-T1D consortium. - Monitor the program page for updates on the NOFO release, application instructions, and deadlines. --- ## Additional Information - The opportunity supports hypothesis-driven research using CARE-T1D resources. - Collaborative and interdisciplinary projects are encouraged, especially those leveraging omics and molecular approaches. - No cost sharing or matching is required. --- ## External Links - [Grant opportunity forecast and application details (Grants.gov)](https://www.grants.gov/search-results-detail/360626) - [National Institutes of Health](https://www.nih.gov/) --- ## Contact Information | Name | Email | Phone | |----------------------------------------------|--------------------------------------------|---------------| | Chandima Nishadi De Abrew Rajapakse, PhD, MHS| [Chandima.rajapakse@nih.gov](mailto:Chandima.rajapakse@nih.gov) | 240-429-5197 |

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research

Sign in to see full grant listing